• SENSEX 82,188.99
    746.95 (+0.92%)
  • BANKNIFTY 56,578.40
    817.55 (+1.47%)
  • Cochin Shipyard
    2,547.25 2,977.10(%)
  • Azad Engineering
    1,561.00 1,128.40(%)
  • Garden Reach Sh.
    3,199.05 1,180.10(%)
  • HDFC Bank
    1,996.30 1,996.30(%)
  • Reliance Industr
    1,451.35 1,608.95(%)
  • Reliance Power
    63.13 63.39(%)
  • Natl. Aluminium
    190.90 263.10(%)
  • HFCL
    92.19 171.00(%)
  • Ramkrishna Forg.
    674.40 1,064.00(%)
  • Suzlon Energy
    66.10 46.00(%)
  • IDFC First Bank
    72.25 84.50(%)
  • Sika Interplant
    1,265.00 399.96(%)
  • Multi Comm. Exc.
    7,529.95 7,529.95(%)
  • St Bk of India
    816.45 898.80(%)
  • Mazagon Dock
    3,380.30 1,417.20(%)
  • Hindustan Zinc
    510.75 717.10(%)
  • ICICI Bank
    1,461.95 1,471.10(%)
  • REC Ltd
    417.30 653.90(%)
  • Eternal Ltd
    264.10 304.50(%)
  • Bharat Electron
    389.05 240.15(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Alkem Laboratories Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 19299.0
  • ISIN : INE540L01014
4,862.50 19 (0.39%)
  • As on 07 Jun 2025 (EOD)
  • Today’s Low

    4,811.00
  • Today’s High

    4,923.00
  • Open

    4,868.00
  • Perv Close

    4,843.50
  • 52W Low

    4,491.65
  • 52W High

    6,439.90

Key Indicators

  • P/E(TTM)

    27.83

  • Mar.Cap (₹Cr.)

    58,138.48

  • Div & Yield %

    0.76

  • Book Value(₹)

    984.46

  • Debt-Equity Ratio

    0.39

  • AGM Date

    06-Jun-2025

  • EPS

    174.78

  • P/E Ratio

    27.83

Financials Ratios

  • Debt-Equity Ratio

    0.15

  • Mar.Cap (₹Cr.)

    58,138.48

  • RONW (%)

    18.72

  • ROCE (%)

    18.29

Score Board

  • Equity (₹ in Cr.)

    23.91

  • BV (₹)

    984.50

  • Sales( ₹ in Cr.)

    8,813.44

  • NP (in Cr.)

    2,089.72

  • NP Var(%)

    16.0

  • Div%

    1850.0

  • CPS (₹)

    198.50

  • EPS (₹)

    174.80

  • Traded Value (₹ in Lakhs)

    58,167.77

  • 52 Week High

    6,439.90

  • 52 Week Low

    4,491.65

  • Price BSE

    4865.0

  • Price NSE

    4,863.00

  • Market Capital( in Cr.)

    58,167.77

  • P/C Ratio

    24.50

  • P/E Ratio

    27.80

  • Price Vs.BV

    174.80

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 9,747.72 9,054.55 8,829.81 7,219.68 6,677.08 5,714.09
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 9,747.72 9,054.55 8,829.81 7,219.68 6,677.08 5,714.09
Other Income 305.99 266.29 199.89 190.01 95.98 67.58
Stock Adjustments 71.31 -257.73 360.90 301.29 33.69 -86.56
Total Income 10,125.02 9,063.11 9,390.60 7,710.98 6,806.75 5,695.11
EXPENDITURE :            
Raw Materials 3,878.63 3,572.91 3,926.79 2,966.31 2,584.25 2,185.31
Power and Fuel Cost 123.85 126.32 129.53 100.12 106.08 99.09
Employee Cost 1,560.28 1,516.22 1,434.49 1,158.72 1,066.76 960.09
Other Manufacturing Expenses 439.03 361.12 399.80 280.51 276.78 270.72
Selling and Administration Expenses 1,608.76 1,739.71 1,438.80 1,007.42 1,160.90 1,013.41
Miscellaneous Expenses 307.18 103.59 50.94 71.74 48.35 53.20
Employee Benefit Expenses 1,560.28 1,516.22 1,434.49 1,158.72 1,066.76 960.09
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 7,917.73 7,419.87 7,380.35 5,584.82 5,243.12 4,581.82
Operating Profit 2,207.29 1,643.24 2,010.25 2,126.16 1,563.63 1,113.29
Interest 81.91 86.40 37.90 42.93 38.71 28.26
Gross Profit 2,125.38 1,556.84 1,972.35 2,083.23 1,524.92 1,085.03
Depreciation 244.35 229.85 218.98 198.93 186.84 141.07
Profit Before Tax 1,881.03 1,326.99 1,753.37 1,884.30 1,338.08 943.96
Current Tax 333.28 227.52 303.82 331.83 246.95 200.41
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -199.40 -35.00 -91.70 -132.61 -173.29 -56.29
Reported Net Profit 1,747.15 1,134.47 1,541.25 1,685.08 1,264.42 799.84
Extraordinary Items -54.86 -10.24 1.82 16.49 3.07 -1.43
Adjusted Net Profit 1,802.01 1,144.71 1,539.43 1,668.59 1,261.35 801.27
Adjustment below Net Profit 0.00 0.00 0.00 0.00 -73.21 -36.45
P & L Balance brought forward 7,431.77 6,823.39 5,700.62 4,350.32 3,517.81 2,933.77
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 538.04 526.09 418.48 334.78 358.70 179.35
P & L Balance carried down 8,640.88 7,431.77 6,823.39 5,700.62 4,350.32 3,517.81
Dividend 0.00 0.00 0.00 0.00 0.00 95.65
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 2,000.00 2,500.00 1,700.00 1,500.00 1,250.00 800.00
Dividend Per Share(Rs) 40.00 50.00 34.00 30.00 25.00 16.00
Earnings Per Share-Unit Curr 146.14 94.90 128.92 140.95 105.76 66.90
Earnings Per Share(Adj)-Unit Curr 146.14 94.90 128.92 140.95 105.76 66.90
Book Value 882.86 782.09 731.38 637.87 525.34 457.15
Book Value(Adj)-Unit Curr 882.86 782.09 731.38 637.87 525.34 457.15

Shareholding Pattern

  • Promoter Group

    55.13%

  • Public Share Holding

    44.87%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 65,913,109 55.13 65,913,109 26
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 65,913,109 55.13 65,913,109 26
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 2,184 0.00 2,184 1
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 14 0.00 14 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 11,248,573 9.41 11,248,573 473
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 3,824,682 3.20 3,824,682 20
Mutual Funds / UTI 17,898,620 14.97 17,898,620 27
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 1,491,137 1.25 1,491,137 13
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 34,465,210 28.83 34,465,210 535
2] Non Institution
Bodies Corporate 130,239 0.11 130,239 683
Clearing Members 32,728 0.03 32,728 7
Directors of their Relatives 1 0.00 1 1
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 105,577 0.09 105,577 2,620
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 44,486 0.04 44,486 2,156
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 17,215,944 14.40 17,215,944 12
Individuals holding nominal share capital up to Rs. 1 lakh 1,639,974 1.37 1,639,974 78,210
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 26 0.00 26 1
Others 505 0.00 505 2
Sub Total 19,186,681 16.05 19,186,681 83,765
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 119,565,000 100.00 119,565,000 84,326

Company Background

Alkem Laboratories LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Alkem Laboratories Ltd
  • BSE Code : 19299.0
  • ISIN : INE540L01014
  • Incorporation Year

    1973

  • Registered Office

    Alkem House SenapatiBapat Marg
    Lower Parel, Mumbai,
    Maharashtra-400013

  • Telephone

    91-22-39829999

  • FAX

    91-22-24952955

  • Chairman

    Basudeo N Singh

  • Managing Director

    SANDEEP SINGH

  • Company Secretary

    Manish Narang

  • Auditor

    B S R & Co LLP/Deloitte Haskins & Sells LLP

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Alkem Laboratories Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Alkem Lab 4,864.95 10,053.71 9,747.72 25.50 17.28
Abbott India 31,751.10 6,097.18 5,848.91 47.70 44.71
Astrazeneca Phar 9,791.90 1,330.33 1,295.53 211.49 33.26
P & G Health Ltd 5,550.45 1,166.89 1,151.26 36.68 39.76
Glaxosmi. Pharma 3,431.50 3,866.05 3,723.49 63.25 58.72
Cipla 1,503.75 17,645.00 16,574.34 23.55 20.10
Amrutanjan Healt 714.85 437.58 421.23 40.66 20.84
Guj. Themis Bio. 322.55 174.19 169.82 72.00 44.82
Fermenta Biotec. 321.90 315.24 307.09 14.01 4.10
Bliss GVS Pharma 136.50 638.96 605.46 20.84 11.19
Ambalal Sarabhai 35.88 11.70 3.81 33.22 1.92